B. Frank Gupton, Ph.D.
B. Frank Gupton, Ph.D.
B. Frank Gupton, Ph.D., is the Floyd D. Gottwald Professor and Chair of the Department of Chemical and Life Science Engineering at the Virginia Commonwealth University School of Engineering. His thirty year industrial career has centered on the development and commercialization of chemical processes for pharmaceutical and agricultural applications. As Executive Director of Chemical Process Development at Boehringer Ingelheim Pharmaceuticals, he led the development and commercialization of the chemical process for the production of Nevirapine, a widely-prescribed antiviral medication for the treatment of AIDS. Gupton holds a B.S. in chemistry from the University of Richmond, an M. S. in biochemistry from the Georgia Institute of Technology, and a Ph.D. in chemistry from VCU.
Ryan Littich, Ph.D.
Ryan Littich, Ph.D.
Ryan leads M4ALL’s API Development Services, Manufacturing Science and Technology, and Facilities & Safety organizations. Before joining M4ALL, Ryan was Head of Advanced Chemistry Technologies, Global R&D at Lonza, a leading pharmaceutical contract development and manufacturing organization. At Lonza, he built and led technology innovation programs, portfolios, and organizations (US, Switzerland, and China) pursuing reductions in API manufacturing costs, production timelines, and environmental impact.
During his tenure at Lonza, Ryan also held leadership positions in Commercial Development (technical product strategy; new business development, validation, and divestiture) and in Strategy & Planning (M&A diligence, multiyear business strategy development and execution; strategic programs leadership).
Ryan holds a Ph.D. in Organic Chemistry from the University of Texas at Austin and an Executive Certificate in Strategy & Innovation for MIT’s Sloan School of Management.
Jennifer Brendel
Jennifer Brendel
Chief Business Officer